z-logo
open-access-imgOpen Access
Immunochemical Characterization of the Specific Sequence of URG7 Protein
Author(s) -
Angela Ostuni,
Flavia Cuviello,
Salvia Am,
Francesco D’Auria,
Teodora Statuto,
Di Nardo E,
Rocchina Miglionico,
Carretta,
P. Musto,
Faustino Bisaccia
Publication year - 2016
Publication title -
journal of biomolecular research and therapeutics
Language(s) - English
Resource type - Journals
ISSN - 2167-7956
DOI - 10.4172/2167-7956.1000146
Subject(s) - characterization (materials science) , sequence (biology) , computational biology , biology , biochemistry , materials science , nanotechnology
URG7 is an anti-apoptotic protein which consists of 99 amino acid residues up regulated by antigen x during the\udHBV infection. The first 74 amino acids are identical to those of the multidrug resistance protein 6 (MRP6), while the\udamino acid residues from 75 to 99 are specific for URG7 protein. Immuno-informatics tools and secondary structure\udanalysis were carried out to identify the antigenic properties of this URG7 sequence. The 75-99 peptide was\udsynthesized by the solid-phase method, structurally characterized by CD spectroscopy and conjugated to a protein\udcarrier. New Zealand white rabbits were immunized and sera were tested for anti-peptide specific antibodies by\udELISA and western blot analysis. Finally ELISA test with human sera was performed.\udRabbits immunized with the 75-99 peptide produce antibodies that recognize both the 75-99 peptide and the\udURG7 recombinant polypeptide. Moreover, both antigens allowed for the detection of the anti-URG7 antibodies in\udsera of healthy and HBV infected subjects although with a different discriminant threshold. Our data suggested that\udpeptide ELISA assay against the specific sequence of the URG7 protein allows with good sensitivity and specificity\udfor the detection of anti-URG7 antibodies in sera from HBV infected patients

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here